首页> 外国专利> COMPOSITION AND STUDY OF NEW MORPHOLINE DERIVATIVES WITH CHOLESTEROL AND LIPID CONCENTRATION REDUCING AND ANTIOXIDANT ACTION

COMPOSITION AND STUDY OF NEW MORPHOLINE DERIVATIVES WITH CHOLESTEROL AND LIPID CONCENTRATION REDUCING AND ANTIOXIDANT ACTION

机译:胆固醇降低脂质浓度和抗氧化剂作用的新型吗啉衍生物的组成和研究

摘要

The present invention relates to the formulation and study of the antioxidant, cholesterol and lipid concentration reducing activity of substituted morpholine derivatives of formula (I)*where R1=CH2CH3; R2=CH3; R3, R4=H, R5=C6H5 or R1=CH2CH2CH2ONO2; R2-CH3; R3, R4=H; R5=C6H5 orR1=H; R2, R3=(CH2)4, R4=H, R5-C6H5 orR1=CH2CH2CH3; R2-R3=(CH2)4, R4=H, R5-C6H5 orR1=CH2CH2CH2ONO2; R2-R3-(CH2)4, R4=H; R5=C6H5 orR1=CH2CH2CH3; R2=CH3; R3-R4=(CH2)4, R5=C6H5 orR1=CH2CH2CH2ONO2; R2=CH3; R3-R4=(CH2)4, R5=C6H5 orR1=CH2CH2CH2ONO2; R2=CH3, R3, R4=H, R5=H orR1=H, R2=p-NO2-C6H4-CH2CH2, R3, R4=H, R5-C6H5.The 2-hydroxy-morpholine derivatives are composed by the reaction of the respective aminoalcohol (22mmol) and 2-bromo-4-phenl acetone (10 mmol) or 2-bromoacetophenone (10 mmol) in ether and acetone for 15 hours at room temperature, whereas the 2-alkoxy-derivatives are composed from the respective 2-hydroxy-derivatives by reaction with the respective alcohol in an acidic environment and heating until they boil. The nitroesters derivatives, where R1=CH2CH2CH2ONO2 are prepared by reaction of the respective 2-hydroxy derivative with 3-bromopropanol-1 as well as the 2-alkoxy derivatives and the conversion of the 2-bromopropoxy derivatives that results in nitroester by boiling with nitrous silver in acetonitrile for 2 hours.The new compounds significantly reduce the content of total cholesterola, total triglycerides and LDL-cholesterol in the plasma.The new compounds have strong antioxidant activity.The new compounds, featuring such properties, could be effectively used for the treatment of high cholesterol and lipid concentration in the blood and for preventing arteriosclerosis.
机译:本发明涉及式(I)*的取代吗啉衍生物的抗氧化剂,降低胆固醇和降低脂质浓度的活性的配方和研究,其中R1 = CH2CH3; R2 = CH3; R3,R4 = H,R5 = C6H5或R1 = CH2CH2CH2ONO2; R 2 -CH 3; R3,R4 = H; R5 = C6H5或R1 = H; R2,R3 =(CH2)4,R4 = H,R5-C6H5或R1 = CH2CH2CH3; R2-R3 =(CH2)4,R4 = H,R5-C6H5或R1 = CH2CH2CH2ONO2 R2-R3-(CH2)4,R4 = H; R5 = C6H5或R1 = CH2CH2CH3; R2 = CH3; R3-R4 =(CH2)4,R5 = C6H5或R1 = CH2CH2CH2ONO2; R2 = CH3; R3-R4 =(CH2)4,R5 = C6H5或R1 = CH2CH2CH2ONO2; R2 = CH3,R3,R4 = H,R5 = H或R1 = H,R2 = p-NO2-C6H4-CH2CH2,R3,R4 = H,R5-C6H5.2-羟基吗啉衍生物是由在室温下,将各自的氨基醇(22mmol)和2-溴-4-苯基丙酮(10 mmol)或2-溴苯乙酮(10 mmol)在乙醚和丙酮中在室温下放置15小时,而2-烷氧基衍生物则分别由通过在酸性环境中与相应的醇反应并加热直至沸腾,生成2-羟基衍生物。 R1 = CH2CH2CH2ONO2的亚硝酸酯衍生物是通过使各自的2-羟基衍生物与3-溴丙醇-1以及2-烷氧基衍生物反应以及将2-溴丙氧基衍生物转化为亚硝酸酯而制得的乙腈中的银2小时。新化合物显着降低血浆中总胆固醇,总甘油三酸酯和LDL-胆固醇的含量,新化合物具有很强的抗氧化活性,具有这些特性的新化合物可有效地用于血脂中。治疗血液中高胆固醇和高脂质的浓度,以及预防动脉硬化。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号